Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
77 studies found for:    Open Studies | "Malabsorption Syndromes"
Show Display Options
Rank Status Study
1 Not yet recruiting Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Conditions: Premature Birth of Newborn;   Intestinal Malabsorption
Interventions: Drug: NTRA-2112;   Drug: Placebo
2 Unknown  The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study
Conditions: Critical Illness;   Malabsorption Syndromes
Interventions: Procedure: Early jejunal feeding (using frictional NJ tube);   Procedure: Standard feeding (using nasogastric [NG] tube)
3 Recruiting Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
Conditions: CVID;   Enteropathy;   Chronic Diarrhea;   Maldigestion;   Malabsorption
Intervention: Biological: Ustekinumab
4 Not yet recruiting Use of a Peptide-based Formula in an Adult Population
Condition: Malabsorption
Intervention: Other: Nutritional Study Product
5 Recruiting Enteral Nutrition and Amino Acid Absorption
Condition: Malabsorption
Intervention: Dietary Supplement: Enteral nutrition
6 Recruiting Investigate the Breath Hydrogen Exhalation After a Test Meal Containing Isomaltulose or Sucrose in Infants
Condition: Malabsorption
Interventions: Dietary Supplement: Isomaltulose;   Dietary Supplement: Sucrose
7 Recruiting Fat Malabsorption in Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Drug: Creon36™
8 Recruiting Whole Milk Intake and Cardio-metabolic Risk Factors
Conditions: Lactose Malabsorption;   Cardiovascular Disease
Intervention: Dietary Supplement: full-fat milk
9 Recruiting A Study of Colesevelam in Fecal Incontinence
Conditions: Fecal Incontinence;   Bile Acid Malabsorption
Interventions: Drug: Colesevelam;   Drug: Clonidine;   Other: Placebo
10 Recruiting Prevalence of Carbohydrate Intolerance in Lean and Overweight/Obese Children
Conditions: Obesity;   Type 2 Diabetes
Intervention: Procedure: Oral Glucose tolerance test
11 Recruiting SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis
Conditions: Exocrine Pancreatic Insufficiency;   Cystic Fibrosis
Intervention: Drug: Liprotamase Powder for Oral Solution
12 Not yet recruiting Vedolizumab Induction May Prevent Celiac Enteritis
Condition: Celiac Disease
Intervention: Drug: Vedolizumab
13 Recruiting Sucrosomial Iron in Patients With Celiac Disease and IDA
Conditions: Celiac Disease;   Iron Deficiency Anemia
Interventions: Dietary Supplement: sucrosomial iron;   Drug: Sulphate iron
14 Recruiting Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies
Condition: Lactose Intolerance
Intervention: Drug: GED
15 Recruiting Non Coeliac Gluten Sensitivity in Children
Conditions: Diet, Gluten-Free;   Gluten-Sensitive Enteropathy
Intervention: Dietary Supplement: gluten
16 Not yet recruiting Safety and Efficacy Study in Infant With SBS
Condition: Short Bowel Syndrome
Interventions: Drug: NTRA-9620;   Drug: Placebo
17 Recruiting Pre-endoscopy Serological Testing for Coeliac Disease; a Novel Approach Using Rapid Antibody Testing
Condition: Celiac Disease
18 Recruiting Small Intestinal Bacterial Overgrowth Obese
Conditions: Gastric Bypass;   Blind Loop Syndrome;   Bacterial Overgrowth Syndrome;   Chromatography, Gas
Interventions: Procedure: gas chromatography;   Procedure: Stool analysis for detection of malabsorption
19 Not yet recruiting Prucalopride Prior to Small Bowel Capsule Endoscopy
Conditions: Gastrointestinal Hemorrhage;   Crohn Disease;   Celiac Disease;   Intestinal Diseases;   Inflammatory Bowel Diseases
Interventions: Drug: Prucalopride;   Drug: Placebo
20 Not yet recruiting Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
Condition: Celiac Disease

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years